Rockwell Medical to acquire Vantive global hemodialysis business under definitive agreement

 

• Rockwell will acquire the majority of Vantive hemodialysis assets and operations, including the Medolla, Italy manufacturing facility.
• Acquired assets include hemodialysis concentrates, monitors and water treatment systems within Vantive’s global hemodialysis business portfolio.
• Transaction consideration totals $125 million upfront plus up to $45 million in contingent consideration.
• Rockwell expects the combined company to generate $400–$450 million in annual revenue after completing the acquisition.
• The acquisition consideration will be financed through loans from Vantive and a Rockwell Medical convertible note.
• Rockwell withdraws its 2026 guidance as part of the Vantive global hemodialysis business acquisition announcement.
• Closing of the Vantive hemodialysis acquisition is expected in mid-2027.

https://finviz.com/stock?t=RMTI&p=d